LIFUS For Neurological Disorders
Trial
N/A
Recruiting
Aug. 12, 2026
Daily Amino Acid Supplementation for People With Parkinson's Disease
Trial
N/A
Recruiting
Aug. 12, 2026
A Targeted Amino Acid Supplement for People With Parkinson's Disease
Trial
Early Phase 1
Completed
Aug. 12, 2026
Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
Trial
N/A
Recruiting
Aug. 11, 2026
Brain Dopamine Biomarker
Trial
N/A
Not yet recruiting
Aug. 11, 2026
Phase â…¢ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
Trial
Phase 3
Not yet recruiting
Aug. 11, 2026
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
Trial
Early Phase 1
Recruiting
Aug. 11, 2026
NAD Supplementation in Parkinson's Disease
Trial
N/A
Enrolling by invitation
Aug. 11, 2026
Studies of Frontal Lobe Brain Functioning in Schizophrenia
Trial
N/A
Completed
Aug. 11, 2026
The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
Trial
Phase 1
Recruiting
Aug. 11, 2026
Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease
Trial
N/A
Recruiting
Aug. 10, 2026
NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study.
Trial
N/A
Completed
Aug. 10, 2026
SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
Trial
N/A
Recruiting
Aug. 10, 2026
A Study of NE3107 in Early Parkinson's
Trial
Phase 2
Completed
Aug. 10, 2026
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease
Trial
N/A
Completed
Aug. 10, 2026
Augmented Reality Treadmill Training in Patients With Parkinson's Disease
Trial
N/A
Terminated
Aug. 9, 2026
Imaging Biomarkers of FOG Response to DBS
Trial
Phase 4
Recruiting
Aug. 9, 2026
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
Trial
Phase 1
Recruiting
Aug. 9, 2026
Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study
Trial
N/A
No longer available
Aug. 9, 2026
Effects of Transcranial Pulse Stimulation in Parkinson's Disease
Trial
N/A
Completed
Aug. 9, 2026